NEOGENOMICS INC — Director's Dealing 2018

Jun 29, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2018-06-29

Reporting Person: SHOVLIN ROBERT J. (President, Clinical Services)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-29	Common Stock	S	12941	$13.12	Disposed	39884	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$7.52	2022-04-28	Common Stock (200000.0)	200000	Direct
Stock Option (Right to Buy)	$8.03	2023-02-26	Common Stock (288500.0)	288500	Direct
Stock Option (Right to Buy)	$4.79	2019-10-13	Common Stock (300000.0)	300000	Direct
Stock Option (Right to Buy)	$7.15	2021-04-20	Common Stock (200000.0)	200000	Direct

Footnotes

F1: Represents the average sales price.

F2: On April 28, 2017, Mr. Shovlin was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F3: On February 26, 2018, Mr. Shovlin was granted 288,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F4: On October 13, 2014, Mr. Shovlin was granted 300,000 stock options. The options have time based vesting. On the first anniversary of the option grant date 75,000 shares vest. Then beginning on the thirteenth (13th) month through the fourth anniversary of the option grant date 6,250 shares will vest on a monthly basis.

F5: On April 20, 2016, Mr. Shovlin was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.